Metronomia news

First US site initiated

The first US site ever was activated for using an eCRF provided by Metronomia in a multinational phase II leukemia trial. 

Read more …

All the best for 2012!

Metronomia wishes you - our customers, partners and visitors - a prosperous and Happy New Year 2012.
We are looking forward to continuing our successfull collaboration in 2012.

Read more …

25.11.2011: Application of propensity score based matching in oncology

Today Metronomia has delivered the statistical report for an indirect comparison of data from a single arm trial in oncology with a historical dataset based on ...  

Read more …

23.11.2011: Critical market access trial in COPD awarded to Metronomia

Today a multinational pharmaceutical customer awarded a critical  market access trial in COPD to Metronomia.

Read more …

12.08.2011: Business Development- eCRFs outperforms paper-CRFs

It' the first time that we at Metronomia see more eCRF project being abwarded to Metronomia than paper-CRF trials. 

Read more …

05.07.2011: Metronomia Social Day

On the 5th of July, Metronomia spent a day working in an asylum-seekers' hostel in Munich.

Read more …

Meet us at the European Clinical Data Forum!

Metronomia is sponsoring the "European Clinical Data Forum", 24 - 25 May 2011 in Munich, Germany.This event bundles two conferences: "eClinical Trials" and "Clinical Data Management", both representing Metronomia’s core business. We are looking forward to welcome you at our booth!

Read more about this event: http://www.arena-international.com

Read more …

Study with innovative stem cell therapy in PAOD initiated in March 2001

Metronomia is providing monitoring, data management and statistical services for a randomized phase II study with innovative stem cell therapy in patients suffering from peripheral arterial occlusive disease. 

Read more …

Contracts with several new bio-pharmaceutical customers signed

During the last three months contracts with three new bio-pharmaceutical and biotech customers were signed. These customers develop therapies mainly in oncology and dermatology (amongst other indications).

Read more …

Statistical and programming services for four transplantation studies awarded to Metronomia

This month significant repeat business was generated: statistical and programming services for four international clinical trials was awarded to Metronomia by one of our long term customers, a global pharmaceutical company.

Read more …